Skip to content

A Comparison of High-flow Nasal Oxygen and Conventional Nasal Cannula in Monitored Anesthesia Care for Endoscopic Submucosal Dissection

A Comparison of High-flow Nasal Oxygen and Conventional Nasal Cannula in Monitored Anesthesia Care for Endoscopic Submucosal Dissection

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06688019
Enrollment
200
Registered
2024-11-14
Start date
2024-11-30
Completion date
2025-10-18
Last updated
2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Undergoing Endoscopic Submucosal Dissection

Brief summary

Sedation for endoscopic submucosal dissection places patients at risk of desaturation, and high-flow nasal oxygen may reduce the risk. The aim of this study is to evaluate the role of high-flow nasal oxygen during endoscopic submucosal dissection. We will compare the incidence of hypoxemia (defined as SpO2 lower than 90%) of conventional nasal oxygen cannula group and that of high-flow humidified oxygen-delivery system group during the procedure.

Interventions

DEVICEconventional oxygenation (nasal cannula)

conventional oxygenation arm will receive oxygen at 2 L/min via nasal cannula, while Optiflow THRIVE arm will receive oxygen at 50 L/min via Optiflow THRIVE during the procedure.

conventional oxygenation arm will receive oxygen at 2 L/min via nasal cannula, while Optiflow THRIVE arm will receive oxygen at 50 L/min via Optiflow THRIVE during the procedure.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Masking description

Patients will be randomly allocated to 2 groups using computer-generated randomization method. Neither participants nor physicians will be blinded to the groups because of organizational reasons.

Intervention model description

Arm 1: conventional nasal cannula group Arm 2: high-flow humidified oxygen-delivery system (OptiFlow THRIVE) group

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients who will undergo endoscopic sumucosal dissection under remimazolam-based sedation

Exclusion criteria

* dementia or cognitive dysfunction * altered mental status * intubated patients or tracheostomy * pregnancy * recent history of nasal bleeding * contraindication for positive pressure ventilation * patients under oxygen therapy * illiteracy or foreigner

Design outcomes

Primary

MeasureTime frameDescription
The incidence of hypoxemia (SpO2 lower than 90%) measured with pulse oximetry during the procedureduring the procedure (from the start to the end of the endoscopic submucosal dissection), 1hourWe will record the incidence of hypoxemia during the procedure.

Secondary

MeasureTime frameDescription
the number and duration of hypoxemiaduring the procedure (from the start to the end of the endoscopic retrograde cholangiopancreatography), 1hourWe will compare the number and duration of hypoxemia, the lowest SpO2 during procedure, need for airway intervention, the end tidal CO2 at the end of the procedure between the two groups.
the lowest SpO2 during procedureduring the procedure (from the start to the end of the endoscopic retrograde cholangiopancreatography), 1hourWe will compare the number and duration of hypoxemia, the lowest SpO2 during procedure, need for airway intervention, the end tidal CO2 at the end of the procedure between the two groups.
need for airway interventionduring the procedure (from the start to the end of the endoscopic retrograde cholangiopancreatography), 1hourWe will compare the number and duration of hypoxemia, the lowest SpO2 during procedure, need for airway intervention, the end tidal CO2 at the end of the procedure between the two groups.
the end tidal CO2 at the end of the procedureduring the procedure (from the start to the end of the endoscopic retrograde cholangiopancreatography), 1hourWe will compare the number and duration of hypoxemia, the lowest SpO2 during procedure, need for airway intervention, the end tidal CO2 at the end of the procedure between the two groups.

Contacts

Primary ContactNamo Kim
namo@yuhs.ac82-2-2224-3200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026